LivaNova PLC and Sorin Group SPA will combine their neuromodulation pipelines with Sorin's cardiac surgery and rhythm management business to create what they say will be a major international player in multiple markets.
The companies announced plans on Feb. 26 to merge, creating a device firm with a much expanded global reach. [See Deal]
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?